News Results for Sarah K. Tasian, MD

1 - 10 of 20

In the News: Novel Genetic Disorder, ‘Peanut Patch,’ Neonatal Outcomes, Seed Grants

Published on May 12, 2023 in Cornerstone Blog
In the News: Novel Disorder, ‘Peanut Patch,’ Neonatal Outcomes, Seed Grants Learn about a novel disorder caused by rare genetic variants, the importance of global neonatal outcomes, and more, in this week’s edition of In the News.

CART38, a Novel Therapy for T-ALL: Q&A With David Teachey, MD, and Caroline Diorio, MD

Published on Jan 19, 2023 in Cornerstone Blog
Seed Grant Funds Research for CART38, a Novel Therapy for T-ALL In this Q&A, Drs. Teachey and Diorio discuss their partnership and research of a novel CAR T-cell therapy for one of the most common pediatric cancers.

In The News: MIS-C, Antibody Treatment for Eosinophilic Esophagitis, ASH 2022

Published on Jan 6, 2023 in Cornerstone Blog
Our Scientists’ Research Highlighted In the News See highlights of work by Children’s Hospital of Philadelphia researchers that is leading to novel findings.

Science Stands Out in Our Most Engaging Cornerstone Stories of 2022

Published on Dec 29, 2022 in Cornerstone Blog
Science Stands Out in Our Most Engaging Cornerstone Stories of 2022 These six Cornerstone stories garnered the most engagements from our CHOP Research Twitter, Facebook, and LinkedIn channels.

ASH 2022: CHOP Experts Presented and Contributed to More than 200 Abstracts at National Hematology Conference

Published on Dec 20, 2022 in Press Releases
Researchers from the Division of Hematology and Division of Oncology attended the 64th Annual American Hematology Society (ASH) Meeting.

In the News: Outstanding Science Award, Highly Cited Researcher, STAT Wunderkinds

Published on Dec 9, 2022 in Cornerstone Blog
In the News This week's news roundup features an outstanding science award, Highly Cited Researchers, and STAT Wunderkinds, along with new research about cancer risk with birth defects, epilepsy, and acute myeloid leukemia.

New Study Shows AML Ages Immune Cells, Leading to Poor Treatment Response

Published on Nov 28, 2022 in Press Releases
A new study has found that acute myeloid leukemia (AML) ages and exhausts immune cells, impairing their ability to fight off cancer.

Where Discovery Leads: Taking CAR T-Cell Therapy to Solid Tumors and Beyond

Published on Sep 19, 2022 in Cornerstone Blog
Where Discovery Leads: CAR T-Cell Therapy Research CHOP physician-scientists discuss their CAR T-cell therapy research for childhood cancers in Where Discovery Leads.

CHOP Researchers Develop Allogeneic CART for Relapsed or Refractory T-ALL Using Base Editing

Published on May 23, 2022 in Press Releases
CHOP researchers have tested and developed an “off-the-shelf” chimeric antigen receptor T-cell (CART) using base editing.

CHOP Researchers Elucidate Mechanism Behind Immunotherapy Resistance in B-ALL

Published on Jan 24, 2022 in Cornerstone Blog
Researchers Find Mechanism of Treatment Resistance in B-ALL Researchers identified aberrant splicing as a culprit behind treatment resistance in B-ALL.
1 - 10 of 20